These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 825032

  • 21. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C, Barry AL, Jones RN, Baker CN, Badal RE, Packer RR.
    Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
    [Abstract] [Full Text] [Related]

  • 22. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I, Tunevall G.
    Scand J Infect Dis Suppl; 1980 Aug; Suppl 23():39-44. PubMed ID: 6782657
    [Abstract] [Full Text] [Related]

  • 23. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [Abstract] [Full Text] [Related]

  • 24. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A, Dibb WL, Benonisen E, Ostervold B.
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [Abstract] [Full Text] [Related]

  • 25. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
    Dhawan V, Marso E, Martin WJ, Young LS.
    Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
    [Abstract] [Full Text] [Related]

  • 26. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH, Koperski K, Scherf H.
    Chemotherapy; 1978 Jan; 24(3):134-42. PubMed ID: 95925
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV, Hamilton-Miller JM, Brumfitt W.
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ, Norden CW.
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [Abstract] [Full Text] [Related]

  • 31. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C, Kauffman CA.
    Infection; 1978 May; 6(3):111-5. PubMed ID: 98451
    [Abstract] [Full Text] [Related]

  • 32. Sisomicin versus netilmicin: in vitro susceptibility testing.
    Flournoy DJ.
    Antimicrob Agents Chemother; 1976 Nov; 10(5):864-5. PubMed ID: 827238
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
    Hindler JA, Bruckner DA.
    J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
    [Abstract] [Full Text] [Related]

  • 34. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J, Hirai CK, Takenaka IM.
    J Int Med Res; 1979 Mar; 7(5):375-8. PubMed ID: 115732
    [Abstract] [Full Text] [Related]

  • 35. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H, Krcméry V.
    Chemotherapy; 1979 Mar; 25(1):23-9. PubMed ID: 105839
    [No Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G, Naumann P, Neussel H, Rosin H.
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [Abstract] [Full Text] [Related]

  • 37. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.
    Levison ME, Kaye D.
    Antimicrob Agents Chemother; 1974 Jun; 5(6):667-9. PubMed ID: 15825423
    [Abstract] [Full Text] [Related]

  • 38. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Murray PR.
    Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
    [Abstract] [Full Text] [Related]

  • 39. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P.
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [Abstract] [Full Text] [Related]

  • 40. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB, Courtieu AL.
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.